Fact CheckerSign in

NCT07236333Completed

The Role of CALLY and HAALP in Ulcerative Colitis

The Role of CALLY and HAALP Scores in the Evaluation of Ulcerative Colitis Attack

Source: ClinicalTrials.gov · Last updated 19 Nov 2025

Brief summary (registry, in English)

The aim of this study is to demonstrate the type and amount of retention in the colon during ulcerative colitis activation, as well as the relationship between C-reactive protein (CRP), albumin and the calculated CALLY index. The investigators also aim to establish whether this ratio can be used to indicate activation.

Status (registry)
Completed
Study type
Observational
Enrollment
100 (actual)
First submitted
24 Sept 2025
Start date
1 Jun 2020
Primary completion date
31 Dec 2024
Lead sponsor
Ataturk University
NCT number
NCT07236333

What you commit to

  • Study type: Observational
  • Participants enrolled: 100
  • From 1 Jun 2020 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • no UC

Who the study is looking for

  • under 18

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Akdeniz University
Coordinator of this site? Confirm its status
AntalyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.